JP7543575B2 - 遊離ヘモグロビン測定試薬、遊離ヘモグロビン測定方法および抗ヘモグロビン抗体 - Google Patents
遊離ヘモグロビン測定試薬、遊離ヘモグロビン測定方法および抗ヘモグロビン抗体 Download PDFInfo
- Publication number
- JP7543575B2 JP7543575B2 JP2023571225A JP2023571225A JP7543575B2 JP 7543575 B2 JP7543575 B2 JP 7543575B2 JP 2023571225 A JP2023571225 A JP 2023571225A JP 2023571225 A JP2023571225 A JP 2023571225A JP 7543575 B2 JP7543575 B2 JP 7543575B2
- Authority
- JP
- Japan
- Prior art keywords
- hemoglobin
- free hemoglobin
- antibody
- reagent
- free
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010054147 Hemoglobins Proteins 0.000 title claims description 227
- 102000001554 Hemoglobins Human genes 0.000 title claims description 227
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 111
- 238000000034 method Methods 0.000 title claims description 73
- 230000009257 reactivity Effects 0.000 claims description 81
- 238000006243 chemical reaction Methods 0.000 claims description 71
- 238000005259 measurement Methods 0.000 claims description 64
- 108010071602 haptoglobin-hemoglobin complex Proteins 0.000 claims description 47
- 230000004520 agglutination Effects 0.000 claims description 37
- 239000002245 particle Substances 0.000 claims description 34
- 102100027685 Hemoglobin subunit alpha Human genes 0.000 claims description 24
- 108091005902 Hemoglobin subunit alpha Proteins 0.000 claims description 24
- 102100021519 Hemoglobin subunit beta Human genes 0.000 claims description 20
- 108091005904 Hemoglobin subunit beta Proteins 0.000 claims description 20
- 238000000691 measurement method Methods 0.000 claims description 18
- 108010036302 hemoglobin AS Proteins 0.000 claims 2
- 102000014702 Haptoglobin Human genes 0.000 description 25
- 108050005077 Haptoglobin Proteins 0.000 description 25
- 239000004816 latex Substances 0.000 description 24
- 229920000126 latex Polymers 0.000 description 24
- 239000004793 Polystyrene Substances 0.000 description 11
- 229920002223 polystyrene Polymers 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 9
- 230000001900 immune effect Effects 0.000 description 8
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000001962 electrophoresis Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 101000856264 Anadara inaequivalvis Globin-1 Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- 239000007995 HEPES buffer Substances 0.000 description 4
- 101001078385 Homo sapiens Haptoglobin Proteins 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 102000050796 human HP Human genes 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000007910 cell fusion Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 150000003278 haem Chemical class 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000012925 reference material Substances 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 210000000628 antibody-producing cell Anatomy 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000003317 immunochromatography Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000004988 splenocyte Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000004926 tubular epithelial cell Anatomy 0.000 description 2
- 241000283707 Capra Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical compound C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 241000609499 Palicourea Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- -1 i.e. Proteins 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 102000014452 scavenger receptors Human genes 0.000 description 1
- 108010078070 scavenger receptors Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022140537 | 2022-09-05 | ||
| JP2022140537 | 2022-09-05 | ||
| PCT/JP2023/032151 WO2024053586A1 (ja) | 2022-09-05 | 2023-09-01 | 遊離ヘモグロビン測定試薬、遊離ヘモグロビン測定方法および抗ヘモグロビン抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2024053586A1 JPWO2024053586A1 (enrdf_load_stackoverflow) | 2024-03-14 |
| JP7543575B2 true JP7543575B2 (ja) | 2024-09-02 |
Family
ID=90191126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571225A Active JP7543575B2 (ja) | 2022-09-05 | 2023-09-01 | 遊離ヘモグロビン測定試薬、遊離ヘモグロビン測定方法および抗ヘモグロビン抗体 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP7543575B2 (enrdf_load_stackoverflow) |
| TW (1) | TW202417843A (enrdf_load_stackoverflow) |
| WO (1) | WO2024053586A1 (enrdf_load_stackoverflow) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010518386A (ja) | 2007-02-12 | 2010-05-27 | ハンソン，ステファン | 子癇前症の診断及び治療 |
| JP2017517753A (ja) | 2014-06-13 | 2017-06-29 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓ Ｈｅａｌｔｈｃａｒｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｉｎｃ． | クロマトグラフ検出パッドを使用する溶血検出 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU529210B3 (en) * | 1983-02-02 | 1983-04-14 | Australian Monoclonal Development Pty. Ltd. | Monoclonal antibody in occult blood diagnosis |
| JPH0324458A (ja) * | 1989-06-21 | 1991-02-01 | Daiso Co Ltd | 尿中赤血球の免疫学的測定法 |
| JPH05209879A (ja) * | 1992-01-31 | 1993-08-20 | Godo Shiyusei Kk | ヘモグロビンの免疫学的検出方法 |
| JPH10132824A (ja) * | 1996-10-28 | 1998-05-22 | Eiken Chem Co Ltd | ヘモグロビンの安定化方法 |
| JPH11201969A (ja) * | 1998-01-14 | 1999-07-30 | Wakamoto Pharmaceut Co Ltd | 簡易遊離ヘモグロビン測定方法および測定用キット |
-
2023
- 2023-09-01 JP JP2023571225A patent/JP7543575B2/ja active Active
- 2023-09-01 WO PCT/JP2023/032151 patent/WO2024053586A1/ja unknown
- 2023-09-05 TW TW112133741A patent/TW202417843A/zh unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010518386A (ja) | 2007-02-12 | 2010-05-27 | ハンソン，ステファン | 子癇前症の診断及び治療 |
| JP2017517753A (ja) | 2014-06-13 | 2017-06-29 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓ Ｈｅａｌｔｈｃａｒｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｉｎｃ． | クロマトグラフ検出パッドを使用する溶血検出 |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202417843A (zh) | 2024-05-01 |
| WO2024053586A1 (ja) | 2024-03-14 |
| JPWO2024053586A1 (enrdf_load_stackoverflow) | 2024-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7508494B2 (ja) | ヘモグロビンの測定試薬、測定キット及び測定方法 | |
| JP6172163B2 (ja) | 検体中のヘモグロビンＡ１ｃの免疫測定方法 | |
| CN101517412B (zh) | 凝集抑制测定法以及凝集抑制测定用试剂 | |
| US20110081731A1 (en) | Method of Assaying Antigen and Reagent Therefor | |
| JP5199067B2 (ja) | 免疫凝集反応試薬キット及び抗原の測定方法 | |
| JP7382071B2 (ja) | 糖化ヘモグロビン（％）の測定方法 | |
| JP2677753B2 (ja) | 凝集イムノアッセイ法 | |
| JP2016031250A (ja) | 標的タンパク質の測定試薬および該試薬を用いた測定方法 | |
| JP7543575B2 (ja) | 遊離ヘモグロビン測定試薬、遊離ヘモグロビン測定方法および抗ヘモグロビン抗体 | |
| JPH04248465A (ja) | 結合可能なアナライトを測定するための免疫沈降法、およびこの方法を実施するための試薬 | |
| KR101726181B1 (ko) | 면역크로마토그래피 분석용 디바이스 | |
| WO2024106336A1 (ja) | 遊離ヘモグロビン測定方法および遊離ヘモグロビン測定試薬 | |
| WO2022163605A1 (ja) | 免疫学的測定方法 | |
| JP4488460B2 (ja) | 免疫分析方法および試薬 | |
| WO2024181457A1 (ja) | 脱糖鎖化ハプトグロビンを用いたヘモグロビンの免疫学的測定方法 | |
| JPH04329357A (ja) | 免疫学的測定方法 | |
| JPH0829420A (ja) | 免疫反応干渉作用の除去方法 | |
| CN118191302B (zh) | 粪便样本中的目的分析物的免疫测定试剂 | |
| US20250224393A1 (en) | Method and kit for reducing interferences in immunoassays | |
| JPH05113442A (ja) | 免疫比濁測定方法 | |
| JPS63206657A (ja) | 蛋白の定量方法 | |
| JPH09281104A (ja) | 偽陰性反応防止方法 | |
| WO2024004805A1 (ja) | 免疫学的測定方法 | |
| WO2022050264A1 (ja) | 免疫学的測定法 | |
| JPH1048210A (ja) | 特異結合分析における感度調節方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231115 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20231115 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240206 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240408 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240606 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240813 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240821 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7543575 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |